The Vaxzevria COVID-19 vaccine – benefit-risk ratio during clinical manufacturing

The first generation of COVID-19 vaccines were developed and approved in record time. As illustrated below, the pressure was immense, and practical solutions were often chosen during development in order to prevent delays in reaching market approval.